Oruka Therapeutics Inc. Common Stock vs Veralto Corp Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Veralto Corp Common Stock trades at $100.6 (market cap $24.13B). The key difference: Veralto Corp Common Stock is far larger — about 4.7× Oruka Therapeutics Inc. Common Stock's market cap, and Veralto Corp Common Stock pays a 0.53% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Veralto Corp Common Stock for 0 Days on average.
| ORKA | VLTO | |
|---|---|---|
Market Cap | $5.18B | $24.13B |
Volume | 490,798 | 1,906,414 |
Sector | Health | Industrials |
52-Week High | $113.08 | $104.87 |
52-Week Low | $26.19 | $82.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $25.39B |
Dividend Yield | — | 0.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Veralto Corporation provides water quality and product quality technologies through two segments, Water Quality and Product Quality & Innovation. Its offerings include water analytics and treatment instruments, marking and coding equipment for packaging, and color measurement solutions such as X-Rite.
Read more on VLTO →